Finance

Lists
001540:KOSDAQ
AHN-GOOK PHARMACEUTICAL Co Ltd
â‚©11,010.00
+0.73%
(+80.00) 1D
Aug 31, 3:30:21 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001540...
Open
â‚©10,910
High
â‚©11,060
Low
â‚©10,710
Mkt. cap
143.60B
Avg. vol.
106.52K
Volume
33.63K
Dividend
5.75%
Quarterly dividend
â‚©158
Ex-dividend date
Dec 27, 2023
P/E ratio
5.78
52-wk high
â‚©13,650
52-wk low
â‚©7,280
EPS
â‚©1,905
Shares outstanding
13.04M
No. of employees
391
Open
â‚©10,910
High
â‚©11,060
Low
â‚©10,710
Mkt. cap
143.60B
Avg. vol.
106.52K
Volume
33.63K
Dividend
5.75%
Quarterly dividend
â‚©158
Ex-dividend date
Dec 27, 2023
P/E ratio
5.78
52-wk high
â‚©13,650
52-wk low
â‚©7,280
EPS
â‚©1,905
Shares outstanding
13.04M
No. of employees
391
About AHN-GOOK PHARMACEUTICAL Co Ltd
CEOWon Deok-kwon
Employees391
Founded1959
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
77.69B
76.61B
98.93B
91.85B
Cost of goods sold
26.19B
25.67B
32.81B
30.18B
Cost of revenue
26.19B
25.67B
32.81B
30.18B
Research and development expenses
4.68B
12.66B
3.81B
4.92B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.21B
43.59B
45.53B
47.31B
Operating expense
46.62B
56.84B
50.10B
53.03B
Total operating expenses
72.81B
82.52B
82.91B
83.21B
Operating income
4.88B
-5.91B
16.02B
8.64B
Other non operating income
5.71M
455.18M
-291.62M
1.46B
EBT including unusual items
4.43B
-5.52B
15.84B
11.43B
EBT excluding unusual items
4.30B
-6.27B
15.35B
8.51B
Income tax expense
1.07B
-2.91B
3.45B
2.86B
Effective tax rate
24.15%
52.69%
21.77%
25.01%
Other operating expenses
-
-
-
-
Net income
3.37B
-2.58B
12.37B
8.50B
Net profit margin
4.33%
-3.37%
12.51%
9.25%
Earnings per share
-
-
-
-
Interest and investment income
105.12M
122.27M
93.74M
150.99M
Interest expense
-661.98M
-647.18M
-634.58M
-666.04M
Net interest expenses
-556.87M
-524.92M
-540.83M
-515.05M
Depreciation and amortization charges
676.60M
458.82M
647.54M
665.23M
EBITDA
7.06B
-3.66B
18.38B
11.21B
Gain or loss from assets sale
1.00K
-25.97M
-
242.90M
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps